Chronic treatment of HD mice (R6/2) with several agonists (CGS21680, T1-11) of A2AR markedly delayed disease progression and reduced the accumulation of the disease-causing protein (mHTT) [47, 54, 113]. This evidence concerns the gene ADORA2A and Huntington disease.